ERBB2 and cervical adenocarcinoma: In this study, we examined the expression of receptor tyrosine kinases, EGFR, HER2 and c-MET, in cervical adenocarcinomas to determine whether they are useful as prognostic factors and therapeutic targets of cervical cancers, with focus on the importance of co-expression of multiple RTKs.